Janssen Pharmaceutica

Skip to main content

Search

Overview
Tissue Platforms
- Diseases
- Cell Assay Datasets
Probes
- Chemical Probes
- Biological probes
Antibodies
Structures
ChromoHub
Publications

Publication partner logo

Publication partner link

https://www.janssen.com

A genetics-led approach defines the drug target landscape of 30 immune-related traits.

Read more about A genetics-led approach defines the drug target landscape of 30 immune-related traits.

Fang, H., De Wolf, H., Knezevic, B., Burnham, K., Osgood, J., Sanniti, A., ... Knight, J. (2019). A genetics-led approach defines the drug target landscape of 30 immune-related traits. Nature Genetics, 51(7), 1082-1091.

Subscribe to Janssen Pharmaceutica

The ULTRA-DD project is supported by the Innovative Medicines Initiative Joint Undertaking (IMI JU) under grant agreement n° [115766], resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. This website reflects only the author’s views and neither IMI nor the European Commission is liable for any use that may be made of the information contained therein.

This website is licensed under a CC-BY licence | Accessibility